Nurix Therapeutics (NRIX) Research & Development (2019 - 2026)
Nurix Therapeutics (NRIX) posted Research & Development of $79.26 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), down 8.0% from $86.12 million a year earlier and down 9.6% from the prior quarter.
Nurix Therapeutics (NRIX) Research & Development (2019 - 2026) Analysis & Trends
For the trailing twelve months through Aug 31, 2026, Research & Development at Nurix Therapeutics was $334.07 million, up 11.0% year-over-year; for FY2025 (ended Nov 30, 2025), it was $316.9 million, up 43.0% from FY2024.
- Annual Research & Development has increased for six consecutive fiscal years, with a five-year compound annual growth rate of 36.7% (FY2020 to FY2025).
- In prior fiscal years, Nurix Therapeutics' Research & Development was $221.63 million in FY2024 (+17.2%), $189.15 million in FY2023 (+2.5%), $184.5 million in FY2022 (+58.5%) and $116.43 million in FY2021 (+75.1%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Research & Development since fiscal Q2 2025.
- On a year-over-year basis, Research & Development increased in seven of the last eight quarters, with growth averaging 29.7%.
- The strongest year-over-year quarter for Research & Development in the past five years was fiscal Q1 2022, with growth of 87.5%; the weakest was fiscal Q3 2026, with a decline of 8.0%.
- According to Business Quant data, Research & Development for the three prior fiscal quarters was $87.65 million (Q2 2026), $84.14 million (Q1 2026) and $83.02 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 79.26 Mn |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 79.26 Mn |
| May 31, 2026 | 87.65 Mn |
| Feb 28, 2026 | 84.14 Mn |
| Nov 30, 2025 | 83.02 Mn |
| Aug 31, 2025 | 86.12 Mn |
| May 31, 2025 | 78.10 Mn |
| Feb 28, 2025 | 69.66 Mn |
| Nov 30, 2024 | 67.22 Mn |
| Aug 31, 2024 | 55.48 Mn |
| May 31, 2024 | 48.92 Mn |
| Feb 29, 2024 | 50.01 Mn |
| Nov 30, 2023 | 49.71 Mn |
| Aug 31, 2023 | 47.86 Mn |
| May 31, 2023 | 45.76 Mn |
| Feb 28, 2023 | 45.82 Mn |
| Nov 30, 2022 | 46.11 Mn |
| Aug 31, 2022 | 47.76 Mn |
| May 31, 2022 | 47.49 Mn |
| Feb 28, 2022 | 43.14 Mn |
| Nov 30, 2021 | 36.53 Mn |
Nurix Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();